Headquartered in Durham, NC Fiscal year ends December NYSE: IQV iqvia.com
IQVIA Holdings Inc. (NYSE: IQV) is a global provider of clinical research services, commercial insights, and healthcare intelligence serving the life sciences and healthcare industries. The company operates through two segments: Commercial Solutions, which provides technology-enabled commercial services including data analytics, real-world evidence, and commercialization support; and Research & Development Solutions, which delivers clinical trial management, regulatory services, and drug development support. IQVIA's offerings are powered by its Connected Intelligence platform, combining proprietary health data, Healthcare-grade AI, advanced analytics, and domain expertise. With approximately 95,000 employees operating in over 100 countries, the company supports biotech, medical device, and pharmaceutical companies, as well as medical researchers, government agencies, and payers. IQVIA has deployed over 400 AI agents and continues to expand its AI-powered solution penetration across clinical and commercial applications. Updated
The CRO demand drought is over: net new clinical bookings of $3.2 billion marked the strongest clinical quarter since 2022. Management raised full-year adjusted EPS guidance to $12.90 to $13.00.
While most software companies were retreating, Paycom made an aggressive and unconventional bet on itself, and the market delivered a verdict that caught even seasoned analysts off guard.
Pre-Market Stock Futures: Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX | SPCX Price Prediction) or SpaceX IPO rush is starting to fade…
Thursday's top analyst upgrades and downgrades included American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines, Taiwan Semiconductor Manufacturing and Toast.
Tuesday's top analyst upgrades and downgrades included Cheniere Energy, Disney, Intel, Salesforce, Toyota, and Wynn Resorts.
Monay's top analyst upgrades and downgrades included Block, Boeing, Chegg, Chesapeake Energy, DexCom, Duke Realty, JPMorgan Chase, Kraft Heinz, Merck, Netflix, Patterson-UTI Energy and TechnipFMC.
Wednesday's top analyst upgrades and downgrades included Albemarle, Camping World, eBay, EOG Resources, Etsy, Global Payments, IMAX, JPMorgan Chase, MetLife, Otis Worldwide, Salesforce, Wayfair and Zillow.
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
Monday's top analyst upgrades, downgrades and initiations included ABB, Apple, Baidu, Casper Sleep, General Electric, Groupon, JPMorgan, Micron Technology, PPD, Verizon Communications and Wayfair.
Here are Credit Suisse's most recently added #1 Top Picks for 2020, including Honeywell and Micron Technology.
IQVIA Holdings Inc. (NYSE: IQV) is a global provider of clinical research services, commercial insights, and healthcare intelligence serving the life sciences and healthcare industries.
24/7 Wall St.'s 12-month price target for IQV is $321.04, rated Buy. The Wall Street consensus target is $311.47. IQV price prediction →
